Stacy is passionate about accelerating innovation and entrepreneurship in the consumer health ecosystem. For more than two decades, Stacy has been a leader in translating innovative science into transformative commercial solutions for the health consumer. Her experience includes venture capital investing, intellectual property licensing and strategic partnering, and business strategy and incubation, with deep experience and insights across the life sciences, healthcare, diagnostics, digital health, nutrition and consumer product industries. Stacy joined Johnson & Johnson Innovation in 2014 and is currently Vice President, Consumer Venture Investments and a member of the investment team at Johnson & Johnson Innovation – JJDC. Stacy has global responsibility for investments and portfolio management in the Consumer Health and Health Tech sectors. Prior to joining Johnson & Johnson, Stacy was a partner at Physic Ventures, a venture fund investing in technology-enabled solutions that empower consumers to improve their health and wellbeing, where she led investment activities in personalized health, including an investment in T2 Biosystems (NASDAQ: TTOO). Previously, Stacy held business development positions at Genentech and Third Wave Technologies and was a technology transactions attorney at Wilson, Sonsini, Goodrich & Rosati.
Stacy is an advisor to Springboard Enterprises' Life Sciences Council, UCSF Clinical and Translational Research Institute T1 Catalyst Program, a mentor for C-Sweetener and a member of the Advisory Council for the University of Texas Horizon Fund and the Investment Advisory Committee for the Reproductive Health Investors Alliance. Stacy has been recognized by Pharm Exec as a 2016 Emerging Leader and in 2018 was named in the Top 10 Global Corporate Venturing Rising Stars.